Combination of interleukin-2 and gamma interferon in metastatic renal cell carcinoma
- 31 December 1993
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (5) , 724-728
- https://doi.org/10.1016/s0959-8049(05)80354-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Therapy of renal cell carcinoma with interleukin-2 and lymphokine-activated killer cells: phase II experience with a hybrid bolus and continuous infusion interleukin-2 regimen.Journal of Clinical Oncology, 1990
- Home therapy with recombinant interleukin-2 and interferon-$alpha;2b in advanced human malignanciesThe Lancet, 1990
- Combination of recombinant interferon alpha-2A and vinblastine in advanced renal cell cancerCancer, 1988
- Recombinant interferon alfa-2a in metastatic renal cell carcinoma: assessment of antitumor activity and anti-interferon antibody formation.Journal of Clinical Oncology, 1988
- Metastatic Renal Cancer Treated with Interleukin-2 and Lymphokine-Activated Killer CellsAnnals of Internal Medicine, 1988
- Phase I/II Study of Recombinant Interferon Gamma in Advanced Renal Cell CarcinomaJournal of Urology, 1988
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinomaCancer, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985